Patents expiring in 2037

AR 103028

COMPUESTOS ANTIBACTERIANOS CON ACCIÓN SOBRE TOPOISOMERASAS

ACRAF [IT] · Granted Wed Apr 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Apr 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2017060524

(E)-N-(2-AMINOPHÉNYL)-3-(1-((4-(1-MÉTHYL-1H-PYRAZOL-4-YL)PHÉNYL)SULFONYL)-1H-PYRROL-3-YL)ACRYLAMIDE POUR LE TRAITEMENT D'INFECTIONS VIRALES LATENTES

4SC AG [DE] · Granted Thu Apr 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 3000894

TRAITEMENT DE LA MASTOCYTOSE SYSTEMIQUE GRAVE PAR LE MASITINIB

AB SCIENCE [FR] · Granted Thu Apr 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9624304

Antibodies which bind to epithelial membrane protein 2 (EMP2)

The Regents of the University of California · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9624306

Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9624268

Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

Protagonist Therapeutics, Inc. · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9624498

Methods and compositions for regulation of zinc finger protein expression

Sangamo Biosciences, Inc. · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9623040

Immunomodulation by controlling expression levels of microRNAs in dendritic cells

The Regents of the University of California · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9623151

Biomaterials and implants for enhanced cartilage formation, and methods for making and using them

The Regents of the University of California · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9624170

4-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (MAGL) inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9623035

Triptolide prodrugs

Regents of the University of Minnesota · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9622991

Hematopoietic growth factor mimetic small molecule compounds and their uses

Ligand Pharmaceuticals Incorporated · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9624233

Compounds for treating pruritic conditions

Trevi Therapeutics, Inc. · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9622983

Sustained-release formulations of topiramate

Supernus Pharmaceuticals, Inc. · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9625473

Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9623103

Arterivirus protein and expression mechanisms

SOUTH DAKOTA BOARD OF REGENTS · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9624509

Modulation of stem cells using zinc finger proteins

Sangamo Biosciences, Inc. · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9623020

Thio compounds

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9624472

Production of insulin producing cells

Regents of the University of Minnesota · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9624475

Genetically stable live attenuated respiratory syncytial virus vaccine and its production

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9622974

Formation of stable submicron peptide or protein particles by thin film freezing

The Board of Regents of the University of Texas · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9624496

Modulation of apolipoprotein C-III expression

Ionis Pharmaceuticals, Inc. · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9624484

Engineered primate L-methioninase for therapeutic purposes

The Board of Regents of the University of Texas System · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9624283

Peptide compounds and methods of production and use thereof

The Board of Regents of the University of Oklahoma · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9624274

Mutated structural protein of a parvovirus

Ludwig-Maximilians-Universitat Munchen · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9624303

Single-chain variable fragment anti-CD133 antibodies and uses thereof

Regents of the University of Minnesota · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9624259

Compositions and methods for scaffold formation

REGENTIS BIOMATERIALS LTD. · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9624255

Carbohydrate-mediated tumor targeting

THE ARIZONA BOARD OF REGENTS · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9624238

4H-thieno[3,2-C]chromene-based inhibitors of Notum Pectinacetylesterase and methods of their use

LEXICON PHARMACEUTICALS, INC. · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9624228

Inhibitors of ERK and methods of use

Kura Oncology, Inc. · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9624211

Anti-cancer compounds

The Board of Regents of the University of Texas System · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9624182

Compounds as lysophosphatidic acid receptor antagonists

AMIRA PHARMACEUTICALS, INC. · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9624184

Heterocyclic compound

Takeda Pharmaceutical Company Limited · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9624156

Compounds and methods for delivery of prostacyclin analogs

United Therapeutics Corporation · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9623124

Multimodal diagnostic technology for early stage cancer lesions

Northwestern University · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9623112

Dually derivatized chitosan nanoparticles and methods of making and using the same

ENGENE, INC. · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9624152

Hydroxyl compounds and compositions for cholesterol management and related uses

Esperion Therapeutics, Inc. · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9623097

Yeast-brachyury immunotherapeutic compositions

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9624229

Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases

Rigel Pharmaceuticals, Inc. · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9623088

Factor VIII polypeptide formulations

BIOVERATIV THERAPEUTICS INC. · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9623085

Chimeric natriuretic peptide compositions and methods of preparation

Capricor Therapeutics, Inc. · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9623055

Method for preventing and/or treating insulin resistance

ACADEMISCH MEDISCH CENTRUM · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9623051

Decellularized extracellular matrix

The Regents of the University of California · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9623091

Factor IX polypeptides and methods of use thereof

BIOVERATIV THERAPEUTICS INC. · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9629877

Human application of engineered chimeric antigen receptor (CAR) T-cells

The Board of Regents of the University of Texas System · Granted Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9629799

Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Rani Therapeutics, LLC · Granted Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9629932

Photodynamic diagnosis, formulations usable as photosensitizers for this purpose, method for the production and use thereof

SANOCHEMIA PHARMAZEUTIKA AG · Granted Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9631193

Compositions and methods for inhibiting expression of the ALAS1 gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)